Real-time enrollment status for this glioma, malignant clinical trial
Current Status
Active, Not Recruiting
Checked: September 1, 2026 at 11:10 AM UTC
| NCT Number | NCT05226494 |
| Recruiting Status | Active, Not Recruiting |
| Condition | Glioma, Malignant |
| Phase | PHASE1 |
| Target Enrollment | 34 participants |
| Active Locations | 1 sites in the US |
| Sponsor | NanoPharmaceuticals LLC |
| Last Updated on CT.gov | August 31, 2026 (Yesterday) |
As of September 1, 2026: Clinical trial NCT05226494 is currently active_not_recruiting participants. This phase1 study for glioma, malignant is not currently accepting new participants at 1 location across the United States. The study is sponsored by NanoPharmaceuticals LLC. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT05226494 is currently active_not_recruiting. The study may resume recruiting in the future.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05226494 was last updated Yesterday (August 31, 2026). HelloStudys verifies this status automatically.